Maintenance Treatment Following First-line Pemetrexed Plus Platinum Chemotherapy The efficacy of pemetrexed as maintenance therapy following first-line platinum-based chemotherapy was also evaluated in PARAMOUNT (NCT00789373), a multi-center, randomized (2:1), double-blind, placebo-controlled study conducted in patients with Stage IIIb/IV non-squamous NSCLC who had completed four cycles of pemetrexed in combination with cisplatin and achieved a complete response (CR) or partial response (PR) or stable disease (SD)
E.MufsonE
(2020) Narrative review: Nutrient deficiencies in adults and children with treated and untreated celiac disease, Nutrients, Vol
Ongoing phase 3 trials for weight loss in non-T2D individuals are now utilizing a similar dosing protocol to that of semaglutide, starting at 0.25 mg/week with gradual titration every four weeks, up to a maximum of 2.4 mg/week [11]
Sourcing quality peptides: Research vendors thoroughly through community testing results, vendor reviews , Certificate of Analysis verification
Sn phm c tc dng chnh ging nh vi tn gi l h tr lm trng da t bn trong